Fusion Financial Statements From 2010 to 2025
| FSPM Stock | USD 0.0001 0.00 0.00% |
Check Fusion Pharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fusion Pharm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Fusion financial statements analysis is a perfect complement when working with Fusion Pharm Valuation or Volatility modules.
Check out the analysis of Fusion Pharm Correlation against competitors. Fusion Pharm Company Operating Margin Analysis
Fusion Pharm's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Fusion Pharm Operating Margin | (1.24) % |
Most of Fusion Pharm's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fusion Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Fusion Pharm has an Operating Margin of -1.2414%. This is 96.46% lower than that of the Consumer Staples Distribution & Retail sector and significantly lower than that of the Consumer Staples industry. The operating margin for all United States stocks is 77.47% lower than that of the firm.
Fusion Pharm Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fusion Pharm's current stock value. Our valuation model uses many indicators to compare Fusion Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fusion Pharm competition to find correlations between indicators driving Fusion Pharm's intrinsic value. More Info.Fusion Pharm is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in profit margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Fusion Pharm by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Fusion Pharm Financial Statements
Fusion Pharm investors utilize fundamental indicators, such as revenue or net income, to predict how Fusion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. The company was founded in 1998 and is based in Commerce City, Colorado. Fusion Pharm operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 4 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Fusion Pharm Correlation against competitors. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.